Current study on diagnosis and treatment of Alzheimer?s disease by targeting amyloid ?-protein

被引：3
作者：
Hua, Kai -Ye [1 ]
Zhao, Wei -Jiang [1 ,2 ]
机构：
[1] Jiangnan Univ, Wuxi Sch Med, Wuxi, Jiangsu, Peoples R China
[2] Jiangnan Univ, Wuxi Sch Med, Cell Biol Dept, 1800 Lihu Dadao, Wuxi 214122, Jiangsu, Peoples R China
来源：
FOLIA NEUROPATHOLOGICA | 2023年 / 61卷 / 01期
关键词：
Alzheimer?s disease; amyloid; pathogenesis; treatment; REDUCES A-BETA; GAMMA-SECRETASE; RISK-FACTORS; CLEARANCE; PLAQUES; MOUSE; OLIGOMERS; BIOMARKER; DEMENTIA; ADAM10;
D O I：
10.5114/fn.2022.119778
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Alzheimer's disease (AD), also known as senile dementia, is a degenerative disease of the central nervous system and is characterized by insidious onset and a chronic progressive course. It is the most common type of senile dementia. Studies have proved that the deposition of amyloid beta (A beta) in the brain is one of the initiating factors correlated to the pathology of AD, and it acts as one of the critical factors leading to the onset of AD. A large number of long-term studies have shown that A beta may be a therapeutic target for a breakthrough in the treatment of AD. This review elucidates the important role of A beta in the development of AD, current research on the role of A beta in AD pathogenesis, and treatment of AD by targeting A beta.
引用
收藏
页码：12 / 15
页数：4
相关论文
共 68 条
  • [21] Complement and microglia mediate early synapse loss in Alzheimer mouse models
    Hong, Soyon
    Beja-Glasser, Victoria F.
    Nfonoyim, Bianca M.
    Frouin, Arnaud
    Li, Shaomin
    Ramakrishnan, Saranya
    Merry, Katherine M.
    Shi, Qiaoqiao
    Rosenthal, Arnon
    Barres, Ben A.
    Lemere, Cynthia A.
    Selkoe, Dennis J.
    Stevens, Beth
    [J]. SCIENCE, 2016, 352 (6286) : 712 - 716
  • [22] ACS Chemical Neuroscience Molecule Spotlight on Begacestat (GSI-953)
    Hopkins, Corey R.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2012, 3 (01): : 3 - 4
  • [23] Shedding light on ADAM metalloproteinases
    Huovila, APJ
    Turner, AJ
    Pelto-Huikko, M
    Kärkkäinen, L
    Ortiz, RM
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (07) : 413 - 422
  • [24] A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
    Iliff, Jeffrey J.
    Wang, Minghuan
    Liao, Yonghong
    Plogg, Benjamin A.
    Peng, Weiguo
    Gundersen, Georg A.
    Benveniste, Helene
    Vates, G. Edward
    Deane, Rashid
    Goldman, Steven A.
    Nagelhus, Erlend A.
    Nedergaard, Maiken
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (147)
  • [25] Passive immunotherapy with a novel antibody against 3pE-modified A? demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice
    Janssens, Jonathan
    Hermans, Bart
    Vandermeeren, Marc
    Barale-Thomas, Erio
    Borgers, Marianne
    Willems, Roland
    Meulders, Greet
    Wintmolders, Cindy
    Van den Bulck, Dries
    Bottelbergs, Astrid
    Ver Donck, Luc
    Larsen, Peter
    Moechars, Dieder
    Edwards, Wilson
    Mercken, Marc
    Van Broeck, Bianca
    [J]. NEUROBIOLOGY OF DISEASE, 2021, 154
  • [26] PAIRED HELICAL FILAMENTS IN ELECTRON MICROSCOPY OF ALZHEIMERS DISEASE
    KIDD, M
    [J]. NATURE, 1963, 197 (486) : 192 - &
  • [27] γ-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
    Kimberly, WT
    LaVoie, MJ
    Ostaszewski, BL
    Ye, WJ
    Wolfe, MS
    Selkoe, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6382 - 6387
  • [28] Sex differences in the association between AD biomarkers and cognitive decline
    Koran, Mary Ellen I.
    Wagener, Madison
    Hohman, Timothy J.
    [J]. BRAIN IMAGING AND BEHAVIOR, 2017, 11 (01) : 205 - 213
  • [29] Researching glutamate - induced cytotoxicity in different cell lines: a comparative/collective analysis/study
    Kritis, Aristeidis A.
    Stamoula, Eleni G.
    Paniskaki, Krystallenia A.
    Vavilis, Theofanis D.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [30] Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial
    Lacosta, Ana-Maria
    Pascual-Lucas, Maria
    Pesini, Pedro
    Casabona, Diego
    Perez-Grijalba, Virginia
    Marcos-Campos, Ivan
    Sarasa, Leticia
    Canudas, Jesus
    Badi, Hassnae
    Monleon, Inmaculada
    San-Jose, Itziar
    Munuera, Josep
    Rodriguez-Gomez, Octavio
    Abdelnour, Carla
    Lafuente, Asuncion
    Buendia, Mar
    Boada, Merce
    Tarraga, Lluis
    Ruiz, Agustin
    Sarasa, Manuel
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2018, 10
1234567